These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 39180495

  • 1. Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1.
    Louis JM, Frias JA, Schroader JH, Jones LA, Davey EE, Lennon CD, Chacko J, Cleary JD, Berglund JA, Reddy K.
    Hum Mol Genet; 2024 Nov 05; 33(21):1873-1886. PubMed ID: 39180495
    [Abstract] [Full Text] [Related]

  • 2. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K, Jenquin JR, McConnell OL, Cleary JD, Richardson JI, Pinto BS, Haerle MC, Delgado E, Planco L, Nakamori M, Wang ET, Berglund JA.
    Proc Natl Acad Sci U S A; 2019 Oct 15; 116(42):20991-21000. PubMed ID: 31570586
    [Abstract] [Full Text] [Related]

  • 3. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM, van Cruchten RTP, Willemse M, Wansink DG.
    PLoS One; 2019 Oct 15; 14(5):e0217317. PubMed ID: 31116797
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L, Huguet-Lachon A, Gourdon G.
    PLoS One; 2015 Oct 15; 10(9):e0137620. PubMed ID: 26339785
    [Abstract] [Full Text] [Related]

  • 6. Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1.
    Wheeler TM, Krym MC, Thornton CA.
    Neuromuscul Disord; 2007 Mar 15; 17(3):242-7. PubMed ID: 17306536
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR, Coonrod LA, Silverglate QA, Pellitier NA, Hale MA, Xia G, Nakamori M, Berglund JA.
    ACS Chem Biol; 2018 Sep 21; 13(9):2708-2718. PubMed ID: 30118588
    [Abstract] [Full Text] [Related]

  • 11. Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development.
    Hale MA, Bates K, Provenzano M, Johnson NE.
    Hum Mol Genet; 2023 Apr 20; 32(9):1413-1428. PubMed ID: 36222125
    [Abstract] [Full Text] [Related]

  • 12. Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics.
    Chau A, Kalsotra A.
    Dev Dyn; 2015 Mar 20; 244(3):377-90. PubMed ID: 25504326
    [Abstract] [Full Text] [Related]

  • 13. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
    Zhang F, Bodycombe NE, Haskell KM, Sun YL, Wang ET, Morris CA, Jones LH, Wood LD, Pletcher MT.
    Hum Mol Genet; 2017 Aug 15; 26(16):3056-3068. PubMed ID: 28535287
    [Abstract] [Full Text] [Related]

  • 14. Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy.
    Christou M, Wengel J, Sokratous K, Kyriacou K, Nikolaou G, Phylactou LA, Mastroyiannopoulos NP.
    Nucleic Acid Ther; 2020 Apr 15; 30(2):80-93. PubMed ID: 31873063
    [Abstract] [Full Text] [Related]

  • 15. Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1.
    Nutter CA, Kidd BM, Carter HA, Hamel JI, Mackie PM, Kumbkarni N, Davenport ML, Tuyn DM, Gopinath A, Creigh PD, Sznajder ŁJ, Wang ET, Ranum LPW, Khoshbouei H, Day JW, Sampson JB, Prokop S, Swanson MS.
    Brain; 2023 Oct 03; 146(10):4217-4232. PubMed ID: 37143315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rescue of Scn5a mis-splicing does not improve the structural and functional heart defects of a DM1 heart mouse model.
    Nitschke L, Hu RC, Miller AN, Cooper TA.
    Hum Mol Genet; 2024 Oct 07; 33(20):1789-1799. PubMed ID: 39126705
    [Abstract] [Full Text] [Related]

  • 18. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
    Wang PY, Lin YM, Wang LH, Kuo TY, Cheng SJ, Wang GS.
    Hum Mol Genet; 2017 Jun 15; 26(12):2247-2257. PubMed ID: 28369378
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.
    López-Martínez A, Soblechero-Martín P, de-la-Puente-Ovejero L, Nogales-Gadea G, Arechavala-Gomeza V.
    Genes (Basel); 2020 Sep 22; 11(9):. PubMed ID: 32971903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.